Trials (IRCCS Ospedale Policlinico San Martino): Revision history

15 December 2025

• curprev 11:0911:09, 15 December 2025‎ Francine talk contribs‎ 114,021 bytes +296‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 113,725 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 23:5323:53, 3 December 2025‎ Larysse talk contribs‎ 112,024 bytes +47‎ No edit summary undo

2 December 2025

• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 111,977 bytes +90‎ Update categories. undo

4 December 2023

• curprev 15:5615:56, 4 December 2023‎ Francine talk contribs‎ 111,887 bytes +111,887‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to IRCCS Ospedale Policlinico San Martino page '''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type met..."